<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-43056" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Telangiectatic Osteosarcoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kuhn</surname>
            <given-names>James</given-names>
          </name>
          <aff>Aventura Hospital and Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tiwari</surname>
            <given-names>Vivek</given-names>
          </name>
          <aff>Apollo Sage Hospital, Bhopal, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khaddour</surname>
            <given-names>Karam</given-names>
          </name>
          <aff>Rosalind Franklin University of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>James Kuhn declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vivek Tiwari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Karam Khaddour declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-43056.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Telangiectatic osteosarcoma is a rare high-grade malignant neoplasm, accounting for less than 10 percent of all cases of osteosarcoma. It is a rare variant of osteosarcoma characterized by distinctive radiographic, gross, and microscopic features. It is a bone-forming tumor that mimics radiologically and histopathologically aneurysmal bone cyst and giant cell tumor. Telangiectatic osteosarcoma is predominantly seen in children, adolescents, and young adults. The mean age at presentation of telangiectatic osteosarcoma is 17.5 years (range from 15 to 20 years) with a male-to-female ratio of 2 to 1. This activity reviews the workup of telangiectatic osteosarcoma and describes the role of the multidisciplinary team of health professionals working together to manage this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the epidemiology of telangiectatic osteosarcoma.</p></list-item><list-item><p>Review the clinical features of telangiectatic osteosarcoma.</p></list-item><list-item><p>Summarize the treatment of telangiectatic osteosarcoma.</p></list-item><list-item><p>Explain modalities to improve care coordination among interprofessional team members in order to improve outcomes for patients affected by telangiectatic osteosarcoma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=43056&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=43056">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-43056.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Osteosarcoma is the most common primary bone malignancy of non-hematopoietic origin. Several subtypes of osteosarcoma have been described on pathological evaluation- conventional, small cell, periosteal, parosteal, high-grade surface, low-grade central, giant cell, and telangiectatic types.<xref ref-type="bibr" rid="article-43056.r1">[1]</xref> Telangiectatic osteosarcoma is a rare, aggressive, high-grade malignant neoplasm, accounting for 2&#x000a0;to 12% of all osteosarcoma cases.<xref ref-type="bibr" rid="article-43056.r2">[2]</xref><xref ref-type="bibr" rid="article-43056.r1">[1]</xref>&#x000a0;It is a rare variant of&#x000a0;osteosarcoma&#x000a0;characterized by distinctive radiographic, gross, and microscopic features. Due to identical radiographic as well as pathological findings, it poses a diagnostic challenge concerning aneurysmal bone cysts and giant cell tumors of bone.<xref ref-type="bibr" rid="article-43056.r3">[3]</xref>&#x000a0;Paget first described this variant in 1853. However, Ewing first thought that it was a type of osteosarcoma. Despite more than 150 years of its description, there lacks a consensus regarding the optimal management for these tumors.<xref ref-type="bibr" rid="article-43056.r4">[4]</xref></p>
      </sec>
      <sec id="article-43056.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact etiology of telangiectatic osteosarcoma is still unknown, and so are&#x000a0;the predisposing factors. It becomes challenging to conduct epidemiological studies and investigate the etiologic factors due to the rare&#x000a0;occurrence of the disease. However, some anecdotal reports described genetic components due to the presence of the disease in family members.<xref ref-type="bibr" rid="article-43056.r5">[5]</xref>&#x000a0;Telangiectatic osteosarcoma was described in the metaphysis of the distal tibia in an 11-year-old girl and the lamina of the thoracic vertebra in an 8-year-old boy who was a cousin. On histopathological evaluation, dilated and proliferated blood cavities were seen along with anaplastic tumor cells&#x000a0;and osteoid production, favoring the diagnosis of telangiectatic osteosarcoma. The clinical outcome was favorable in both cases.<xref ref-type="bibr" rid="article-43056.r5">[5]</xref>&#x000a0;Also, three well-documented cases of extraskeletal telangiectatic osteosarcoma of the soft tissues were described; the daughter of one of the cases had died previously of high-grade intramedullary bone osteosarcoma.<xref ref-type="bibr" rid="article-43056.r6">[6]</xref></p>
      </sec>
      <sec id="article-43056.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Telangiectatic osteosarcoma is predominantly seen in children, adolescents, and young adults. The&#x000a0;mean age at presentation of telangiectatic osteosarcoma is 17.5 years (range from 15 to 20 years) with a male-to-female ratio of 2 to 1.<xref ref-type="bibr" rid="article-43056.r2">[2]</xref> The distal femoral metaphysis is the single most common anatomic site (42%), followed by the proximal tibia (17%), the proximal humerus (9%), and the proximal femur (8%).</p>
        <p>Flat bone involvement is relatively rare, with around 8% incidence of&#x000a0;non-appendicular non-spinal sites.<xref ref-type="bibr" rid="article-43056.r7">[7]</xref><xref ref-type="bibr" rid="article-43056.r8">[8]</xref> Uncommon sites of telangiectatic osteosarcoma include the scapula, the ribs, the sternum, the innominate bone, the cranial vault, and the mandible.&#x000a0;Telangiectatic osteosarcoma of the spine&#x000a0;represents 2% of all cases of primary vertebral osteosarcomas.<xref ref-type="bibr" rid="article-43056.r9">[9]</xref> Extra-osseous&#x000a0;telangiectatic osteosarcoma is rare, with telangiectatic osteosarcoma arising in the soft tissues of the thigh, the forearm, and the popliteal fossa.<xref ref-type="bibr" rid="article-43056.r6">[6]</xref></p>
      </sec>
      <sec id="article-43056.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Histogenesis</bold>
</p>
        <p>Telangiectatic osteosarcoma is presumed to derive from&#x000a0;either transformed osteoblasts or stem cells of mesenchymal origin. Angiosarcomatous&#x000a0;features are present in addition to osteoblast-like and fibroblast-like cells at the ultrastructural level. Tight intercellular junctions,&#x000a0;Weibel-Palade bodies, and pinocytic vesicles&#x000a0;are visible within the cell cytoplasm. These features suggest that telangiectatic osteosarcoma derives from multipotential stem cells of mesenchymal origin.<xref ref-type="bibr" rid="article-43056.r10">[10]</xref><xref ref-type="bibr" rid="article-43056.r2">[2]</xref><xref ref-type="bibr" rid="article-43056.r11">[11]</xref></p>
        <p>
<bold>Cytogenetics</bold>
</p>
        <p>Only seven cases of telangiectatic osteosarcoma to date have had genetic studies. The cytogenetic analysis identified trisomy 3 in one case, and in three other tumors, more complex chromosomal changes&#x000a0;were reported.<xref ref-type="bibr" rid="article-43056.r12">[12]</xref><xref ref-type="bibr" rid="article-43056.r13">[13]</xref> Metaphase CGH identified an average of 2.5 aberrations in two telangiectatic osteosarcomas, and array CGH identified only three regional gains at 1q21-23.2, 1q25.2-31.1, and 7q21.13-21.2 in one tumor.<xref ref-type="bibr" rid="article-43056.r14">[14]</xref> This suggests that telangiectatic tumors are genetically less complex than conventional osteosarcoma.</p>
      </sec>
      <sec id="article-43056.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>On gross as well as microscopic appearance, telangiectatic osteosarcoma very closely resembles aneurysmal bone cysts.<xref ref-type="bibr" rid="article-43056.r4">[4]</xref> Therefore, the resected&#x000a0;surgical specimens of telangiectatic osteosarcoma must undergo meticulous sampling.<xref ref-type="bibr" rid="article-43056.r2">[2]</xref>&#x000a0;Because of the cystic and lytic nature of the tumor, a core-needle biopsy may not provide an adequate and appropriate sample for the diagnosis. Hence, the establishment of the diagnosis often gets delayed leading to delayed treatment with the outcome affected adversely.<xref ref-type="bibr" rid="article-43056.r15">[15]</xref><xref ref-type="bibr" rid="article-43056.r16">[16]</xref><xref ref-type="bibr" rid="article-43056.r2">[2]</xref> The&#x000a0;complete face of the bone must&#x000a0;be sampled&#x000a0;to document&#x000a0;the percentages of the viable and necrotic tumors.<xref ref-type="bibr" rid="article-43056.r2">[2]</xref>&#x000a0;Yin et al. developed and described a diagnostic model for the differentiation of telangiectatic osteosarcoma from an aneurysmal bone cyst.<xref ref-type="bibr" rid="article-43056.r17">[17]</xref>&#x000a0;</p>
        <p>
<bold>Macroscopic Findings</bold>
</p>
        <p>Macroscopic examination reveals a hemorrhagic multicystic lesion filled with blood clots. Telangiectatic osteosarcomas have the classic description as ''a bag of blood.'' They are, by definition, composed of approximately 90% cystic components before treatment.<xref ref-type="bibr" rid="article-43056.r8">[8]</xref> A fleshy sarcomatous component is typically not present. The cystic spaces can vary considerably in size and may occasionally measure several centimeters in diameter. More often, there is a mixture of large cystic and spongy areas. The spongy areas represent tissue honeycombed with smaller cysts measuring up to several millimeters. The borders of the lesion are usually well-demarcated, but often there are features of invasive growth with extensive irregular cortical erosion, complete disruption of cortical continuity, and invasion of soft tissue.</p>
        <p>
<bold>Microscopic Findings</bold>
</p>
        <p>Histologically, telangiectatic osteosarcoma is composed of blood-filled or empty cystic spaces resembling aneurysmal bone cysts. The septa are populated by pleomorphic cells with important nuclear hyperchromasia and also contain osteoclast-like giant cells. Osteoid formation is usually focal and confluent. Because telangiectatic osteosarcoma is sometimes not&#x000a0;adequately sampled by core-needle biopsy due to its lytic and cystic nature, cellular atypia and osteoid formation may be absent, which may lead to misdiagnosis.<xref ref-type="bibr" rid="article-43056.r2">[2]</xref>&#x000a0;Previously, the osteoid production by the malignant cells was deemed essential for diagnosing telangiectatic osteosarcoma. However, later various cases were reported with a lack of osteoid production.<xref ref-type="bibr" rid="article-43056.r4">[4]</xref>&#x000a0;Thickened septa with nodularity, along with the presence of malignant cells with nuclear pleomorphism and cellular atypia, microscopically differentiate telangiectatic osteosarcoma from aneurysmal bone cysts.<xref ref-type="bibr" rid="article-43056.r17">[17]</xref></p>
        <p>
<bold>Immunochemistry</bold>
</p>
        <p>No immunohistochemical studies are useful in the diagnosis of telangiectatic osteosarcoma.</p>
      </sec>
      <sec id="article-43056.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>There is no difference in the clinical presentation of telangiectatic and conventional osteosarcoma. Local pain and/or soft tissue mass are the most common symptoms of telangiectatic osteosarcoma. Sometimes, the patients may present with a pathologic fracture.<xref ref-type="bibr" rid="article-43056.r18">[18]</xref><xref ref-type="bibr" rid="article-43056.r19">[19]</xref> Occasionally, a vascular bruit may be heard over the tumor. As with any other malignant tumor, a thorough general physical and systemic clinical examination is mandatory to look for evidence of any metastases.</p>
      </sec>
      <sec id="article-43056.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Several imaging modalities are available for establishing the diagnosis of telangiectatic osteosarcoma. They include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Plain radiographs</p>
          </list-item>
          <list-item>
            <p>Computed tomography (CT)</p>
          </list-item>
          <list-item>
            <p>Magnetic resonance imaging (MRI)</p>
          </list-item>
        </list>
        <p>
<bold>Radiographic Findings</bold>
</p>
        <p>Telangiectatic osteosarcoma is typically a purely lytic lesion with a permeative destructive growth pattern. This rapidly growing tumor often expands the contour of bone and shows features of cortical disruption with minimal or no periosteal new bone formation.&#x000a0;The massive expansile growth pattern of telangiectatic osteosarcoma can superficially simulate an aneurysmal bone cyst. Telangiectatic osteosarcoma&#x000a0;can have a deceptively innocent radiographic appearance with sharply demarcated margins, simulating a benign bone cyst. Aneurysmal bone cysts generally have type 1A or 1B patterns of geographic bone destruction.<xref ref-type="bibr" rid="article-43056.r20">[20]</xref>&#x000a0;Presence of soft tissue mass, Codman&#x000a0;triangle, and&#x000a0;matrix mineralization point towards the diagnosis of telangiectatic osteosarcoma. MRI best documents the multilocular cystic nature of the lesion and the so-called fluid level sign.<xref ref-type="bibr" rid="article-43056.r21">[21]</xref></p>
        <p>T1-weighted MRI shows heterogeneous low signal intensity, and T2-weighted images show high signal intensity with several cystic foci, fluid levels, and an extra-skeletal extension of the tumor, similar to an aneurysmal cyst, but with irregular walls, septae, and nodular and solid components.<xref ref-type="bibr" rid="article-43056.r7">[7]</xref>&#x000a0;Zishan et al. described that presence of fluid-fluid levels in the lesion was the most useful differentiating MRI feature between telangiectatic osteosarcoma and aneurysmal bone cyst. As compared to 74% of the osteosarcomas demonstrating a fluid level, 95% of the bone cysts had the presence of fluid levels. Also, only aneurysmal bone cysts had lesions that were completely filled with a fluid-fluid level.<xref ref-type="bibr" rid="article-43056.r20">[20]</xref></p>
        <p>The criteria for diagnosing telangiectatic osteosarcoma include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Radiographically, a destructive, osteolytic tumor with little or no matrix mineralization or periosteal new bone formation</p>
          </list-item>
          <list-item>
            <p>Cystic/cavitary gross specimen with little solid tumor tissue and no areas of a dense bone</p>
          </list-item>
          <list-item>
            <p>Histologically, a tumor with single or multiple cystic cavities containing blood or necrotic tissue, with thickened septa composed of anaplastic tumor cells<xref ref-type="bibr" rid="article-43056.r4">[4]</xref></p>
          </list-item>
        </list>
        <p>The high alkaline phosphatase level frequently seen in osteosarcoma is not a feature of telangiectatic osteosarcoma. On the other hand, the evaluation of platelet count, white cell count, lactate dehydrogenase, and alkaline phosphatase have been described for differentiating telangiectatic osteosarcoma from aneurysmal bone cysts. The sarcomas had a higher value of platelet count, white cell count, alkaline phosphatase, and lactate dehydrogenase than the aneurysmal bone cysts.<xref ref-type="bibr" rid="article-43056.r17">[17]</xref></p>
      </sec>
      <sec id="article-43056.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Previously, the prognosis and clinical outcome of telangiectatic osteosarcoma were considered to be poor. However, with the advent of chemotherapy, the prognosis has significantly improved, with around a 60% survival rate at ten years, which is similar to that of conventional osteosarcoma.<xref ref-type="bibr" rid="article-43056.r22">[22]</xref> Patients with telangiectatic osteosarcoma receive neo-adjuvant chemotherapy followed by surgical excision, further followed by adjuvant chemotherapy/ radiotherapy. The pre-chemotherapy era required amputation in most cases of telangiectatic osteosarcoma. However, limb-sparing surgery is now possible in most cases, even with pathological fractures.<xref ref-type="bibr" rid="article-43056.r23">[23]</xref><xref ref-type="bibr" rid="article-43056.r22">[22]</xref><xref ref-type="bibr" rid="article-43056.r24">[24]</xref>&#x000a0;The extent of surgery depends on the size, location, and response to the neoadjuvant therapy. Adjuvant chemotherapy can offer some advantages if metastatic disease is present.</p>
        <p>Colomina et al. reported the outcome of 8 patients with telangiectatic osteosarcoma with pathologic fractures. They described that the presence of a pathologic fracture did not worsen the outcome and had similar survival and recurrence rates.<xref ref-type="bibr" rid="article-43056.r24">[24]</xref>&#x000a0;Similarly, in a retrospective review of 87 cases of telangiectatic osteosarcoma, Angelini et al. reported a survival rate of 60% at ten years. The majority of the patients were cured with neoadjuvant chemotherapy and limb-sparing surgery. They found tumor response to chemotherapy as the only significant prognostic factor affecting survival.<xref ref-type="bibr" rid="article-43056.r22">[22]</xref></p>
      </sec>
      <sec id="article-43056.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The most common differential diagnosis is an aneurysmal bone cyst which closely mimics the radiographic, gross as well as microscopic features of telangiectatic osteosarcoma. This often delays the diagnosis leading to the delay in starting optimal treatment. Other differential diagnoses include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Giant cell tumor of bone</p>
          </list-item>
          <list-item>
            <p>Brodie abscess</p>
          </list-item>
          <list-item>
            <p>Blood clot</p>
          </list-item>
          <list-item>
            <p>Malignant fibrous histiocytoma</p>
          </list-item>
          <list-item>
            <p>Fibrosarcoma<xref ref-type="bibr" rid="article-43056.r4">[4]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43056.s11" sec-type="Treatment Planning ">
        <title>Treatment Planning </title>
        <p>Chemotherapeutic protocols for&#x000a0;telangiectatic osteosarcoma are similar to those of conventional osteosarcoma. Patients will have two to six cycles of chemotherapy administered before surgery. The common&#x000a0;chemotherapeutic agents used include&#x000a0;cisplatin, carboplatin, methotrexate,&#x000a0;doxorubicin, and&#x000a0;ifosfamide.<xref ref-type="bibr" rid="article-43056.r25">[25]</xref> Among these, at least two agents need inclusion in a dual-drug therapy regimen.&#x000a0;The effect of chemotherapy on telangiectatic osteosarcoma&#x000a0;must undergo reassessment. The percentage of tumor necrosis needs to be assessed in the pathological evaluation of the surgical specimen, as &#x0003c;90% necrosis mandates a change in the chemotherapeutic regimen.<xref ref-type="bibr" rid="article-43056.r4">[4]</xref></p>
      </sec>
      <sec id="article-43056.s12" sec-type="Staging">
        <title>Staging</title>
        <p>The two common staging systems for telangiectatic osteosarcoma include the Enneking system for malignant bone neoplasms and the American Joint Committee on Cancer (AJCC) system for staging bone sarcomas. The Enneking system includes tumor histological grade, the local extent of the tumor- intracompartmental or extracompartmental and the presence of metastasis. The AJCC system considers tumor histological grade, tumor size, and the presence and location of metastases.<xref ref-type="bibr" rid="article-43056.r26">[26]</xref></p>
      </sec>
      <sec id="article-43056.s13" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Telangiectatic osteosarcoma usually shows a better response to chemotherapy than conventional osteosarcoma. Survival rates with current chemotherapy protocols are within the range of 65% after five years.<xref ref-type="bibr" rid="article-43056.r27">[27]</xref> The pattern of metastatic spread of telangiectatic osteosarcoma is similar to that seen in conventional osteosarcoma.</p>
        <p>Tumor&#x000a0;necrosis greater than 95% is considered one of the most important prognostic factors.<xref ref-type="bibr" rid="article-43056.r28">[28]</xref> Additionally, uninvolved&#x000a0;neurovascular bundles and soft tissue and bone resection margins are essential for a favorable prognosis.<xref ref-type="bibr" rid="article-43056.r2">[2]</xref>&#x000a0;Yin et al. reported that the level of lactate dehydrogenase and tumor volume were predictive prognostic factors, and the presence of a pathologic fracture did not affect the outcome.<xref ref-type="bibr" rid="article-43056.r17">[17]</xref></p>
      </sec>
      <sec id="article-43056.s14" sec-type="Complications">
        <title>Complications</title>
        <p>The complications in managing telangiectatic osteosarcoma include local recurrence, metastases, decreased survival, implant failure, infection, and cardiotoxicity due to chemotherapy.<xref ref-type="bibr" rid="article-43056.r4">[4]</xref></p>
      </sec>
      <sec id="article-43056.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Telangiectatic osteosarcoma is an aggressive and rare variant of osteosarcoma. In contrast to the previous reports, its prognosis is comparable to conventional osteosarcoma. These tumors have a good response to chemotherapy. However, these tumors have a higher incidence of pathologic fracture owing to the cystic nature of the lesion that weakens the bone.<xref ref-type="bibr" rid="article-43056.r4">[4]</xref></p>
      </sec>
      <sec id="article-43056.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Telangiectatic osteosarcoma is a rare and aggressive variant of osteosarcoma with distinctive radiological and pathological features. It poses diagnostic difficulties, mainly with&#x000a0;an aneurysmal bone cyst. Distinguishing between these two entities is vital since their management and prognosis differ significantly. Telangiectatic osteosarcoma&#x000a0;is&#x000a0;ideally managed&#x000a0;by an interprofessional team that consists of&#x000a0;orthopedists, oncologists, radiologists, pathologists, pharmacists, and specialty care nurses. Pharmacists review chemotherapeutic regimens, check for drug-drug interactions, and provide patient and family education. Specialty care oncology nurses administer chemotherapy, educate patients and their families, monitor for side effects, and give the team feedback on the patient's condition. All team members must maintain accurate and updated patient documentation so all caregivers can access accurate, up-to-date patient data. Interprofessional patient care will result in improved diagnosis, treatment, and outcomes for patients with telangiectatic osteosarcoma. [Level 5]</p>
      </sec>
      <sec id="article-43056.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=43056&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=43056">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/telangiectatic-osteosarcoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=43056">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/43056/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=43056">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-43056.s18">
        <fig id="article-43056.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Telangiectactic Osteosarcoma. X-ray of the humerus bone with numerous blood-filled sinusoids characteristic of telangiectatic osteosarcoma. Image courtesy S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="telangiectactic__OS" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-43056.s19">
        <title>References</title>
        <ref id="article-43056.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yarmish</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Landa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lefkowitz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Imaging characteristics of primary osteosarcoma: nonconventional subtypes.</article-title>
            <source>Radiographics</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>1653</fpage>
            <page-range>1653-72</page-range>
            <pub-id pub-id-type="pmid">21071381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sangle</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Layfield</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Telangiectatic osteosarcoma.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2012</year>
            <month>May</month>
            <volume>136</volume>
            <issue>5</issue>
            <fpage>572</fpage>
            <page-range>572-6</page-range>
            <pub-id pub-id-type="pmid">22540307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turel</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Moses</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rajshekhar</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Primary telangiectatic osteosarcoma of the cervical spine.</article-title>
            <source>J Neurosurg Spine</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>373</fpage>
            <page-range>373-8</page-range>
            <pub-id pub-id-type="pmid">22225487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hua</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>ZD</given-names>
              </name>
            </person-group>
            <article-title>Telangiectatic osteosarcoma: a review of literature.</article-title>
            <source>Onco Targets Ther</source>
            <year>2013</year>
            <volume>6</volume>
            <fpage>593</fpage>
            <page-range>593-602</page-range>
            <pub-id pub-id-type="pmid">23745051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishida</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shiraishi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shimamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tamura</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Satoh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ehara</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Familial occurrence of telangiectatic osteosarcoma: cousin cases.</article-title>
            <source>J Pediatr Orthop</source>
            <year>1994</year>
            <season>Jan-Feb</season>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>119</fpage>
            <page-range>119-22</page-range>
            <pub-id pub-id-type="pmid">8113361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirra</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Fain</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Eckardt</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Eilber</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Extraskeletal telangiectatic osteosarcoma.</article-title>
            <source>Cancer</source>
            <year>1993</year>
            <month>May</month>
            <day>15</day>
            <volume>71</volume>
            <issue>10</issue>
            <fpage>3014</fpage>
            <page-range>3014-9</page-range>
            <pub-id pub-id-type="pmid">8490830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murphey</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>wan Jaovisidha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Temple</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Gannon</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Jelinek</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Malawer</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Telangiectatic osteosarcoma: radiologic-pathologic comparison.</article-title>
            <source>Radiology</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>229</volume>
            <issue>2</issue>
            <fpage>545</fpage>
            <page-range>545-53</page-range>
            <pub-id pub-id-type="pmid">14512511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huvos</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bretsky</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Telangiectatic osteogenic sarcoma: a clinicopathologic study of 124 patients.</article-title>
            <source>Cancer</source>
            <year>1982</year>
            <month>Apr</month>
            <day>15</day>
            <volume>49</volume>
            <issue>8</issue>
            <fpage>1679</fpage>
            <page-range>1679-89</page-range>
            <pub-id pub-id-type="pmid">6950802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ilaslan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sundaram</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Unni</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Shives</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Primary vertebral osteosarcoma: imaging findings.</article-title>
            <source>Radiology</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>230</volume>
            <issue>3</issue>
            <fpage>697</fpage>
            <page-range>697-702</page-range>
            <pub-id pub-id-type="pmid">14749514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roessner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hobik</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Immenkamp</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grundmann</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Ultrastructure of telangiectatic osteosarcoma.</article-title>
            <source>J Cancer Res Clin Oncol</source>
            <year>1979</year>
            <month>Oct</month>
            <volume>95</volume>
            <issue>2</issue>
            <fpage>197</fpage>
            <page-range>197-207</page-range>
            <pub-id pub-id-type="pmid">293331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Metcalf</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Nightingale</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Zenner</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Lui-Roberts</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Cutler</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Formation and function of Weibel-Palade bodies.</article-title>
            <source>J Cell Sci</source>
            <year>2008</year>
            <month>Jan</month>
            <day>01</day>
            <volume>121</volume>
            <issue>Pt 1</issue>
            <fpage>19</fpage>
            <page-range>19-27</page-range>
            <pub-id pub-id-type="pmid">18096688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fletcher</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Gebhardt</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Kozakewich</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes.</article-title>
            <source>Cancer Genet Cytogenet</source>
            <year>1994</year>
            <month>Oct</month>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-8</page-range>
            <pub-id pub-id-type="pmid">7923089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoogerwerf</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Perlman</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Chromosome analysis of nine osteosarcomas.</article-title>
            <source>Genes Chromosomes Cancer</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>88</fpage>
            <page-range>88-92</page-range>
            <pub-id pub-id-type="pmid">7513549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zielenska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marrano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Thorner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pei</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Beheshti</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bayani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Squire</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hao</surname>
                <given-names>XS</given-names>
              </name>
            </person-group>
            <article-title>High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue.</article-title>
            <source>Cytogenet Genome Res</source>
            <year>2004</year>
            <volume>107</volume>
            <issue>1-2</issue>
            <fpage>77</fpage>
            <page-range>77-82</page-range>
            <pub-id pub-id-type="pmid">15305059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khoury</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Hoffer</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Billups</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Heck</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Quintana</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Poe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Daw</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience.</article-title>
            <source>Cancer</source>
            <year>2007</year>
            <month>Apr</month>
            <day>15</day>
            <volume>109</volume>
            <issue>8</issue>
            <fpage>1627</fpage>
            <page-range>1627-37</page-range>
            <pub-id pub-id-type="pmid">17351949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Luu</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Osteosarcoma.</article-title>
            <source>Cancer Treat Res</source>
            <year>2014</year>
            <volume>162</volume>
            <fpage>65</fpage>
            <page-range>65-92</page-range>
            <pub-id pub-id-type="pmid">25070231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yin</surname>
                <given-names>JQ</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>XB</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst.</article-title>
            <source>J Bone Oncol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>11</volume>
            <fpage>10</fpage>
            <page-range>10-16</page-range>
            <pub-id pub-id-type="pmid">29892520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papagelopoulos</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Mavrogenis</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Savvidou</surname>
                <given-names>OD</given-names>
              </name>
              <name>
                <surname>Benetos</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Galanis</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Soucacos</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Pathological fractures in primary bone sarcomas.</article-title>
            <source>Injury</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>395</fpage>
            <page-range>395-403</page-range>
            <pub-id pub-id-type="pmid">18061185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kunze</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>B&#x000fc;rkle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kluba</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Multifocal osteosarcoma in childhood.</article-title>
            <source>Chir Organi Mov</source>
            <year>2009</year>
            <month>May</month>
            <volume>93</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-31</page-range>
            <pub-id pub-id-type="pmid">19711159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zishan</surname>
                <given-names>US</given-names>
              </name>
              <name>
                <surname>Pressney</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Khoo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saifuddin</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The differentiation between aneurysmal bone cyst and telangiectatic osteosarcoma: a clinical, radiographic and MRI study.</article-title>
            <source>Skeletal Radiol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>49</volume>
            <issue>9</issue>
            <fpage>1375</fpage>
            <page-range>1375-1386</page-range>
            <pub-id pub-id-type="pmid">32248448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zeitoun</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shokry</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ahmed Khaleel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mogahed</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Osteosarcoma subtypes: Magnetic resonance and quantitative diffusion weighted imaging criteria.</article-title>
            <source>J Egypt Natl Canc Inst</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-44</page-range>
            <pub-id pub-id-type="pmid">29429892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angelini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mavrogenis</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Trovarelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Picci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ruggieri</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Telangiectatic osteosarcoma: a review of 87 cases.</article-title>
            <source>J Cancer Res Clin Oncol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>142</volume>
            <issue>10</issue>
            <fpage>2197</fpage>
            <page-range>2197-207</page-range>
            <pub-id pub-id-type="pmid">27469493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bacci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ruggieri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Biagini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fabbri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Campanacci</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bacchini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Longhi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Forni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bertoni</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.</article-title>
            <source>Acta Orthop Scand</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>72</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-72</page-range>
            <pub-id pub-id-type="pmid">11372948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colomina</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peiro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Trullols</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Telangiectatic osteosarcoma.</article-title>
            <source>J Orthop Surg (Hong Kong)</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>96</fpage>
            <page-range>96-9</page-range>
            <pub-id pub-id-type="pmid">23629998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basaran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bavbek</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Saglam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eralp</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sakar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Atalar</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Bilgic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ozger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Onat</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas.</article-title>
            <source>Oncology</source>
            <year>2007</year>
            <volume>72</volume>
            <issue>3-4</issue>
            <fpage>255</fpage>
            <page-range>255-60</page-range>
            <pub-id pub-id-type="pmid">18185020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kundu</surname>
                <given-names>ZS</given-names>
              </name>
            </person-group>
            <article-title>Classification, imaging, biopsy and staging of osteosarcoma.</article-title>
            <source>Indian J Orthop</source>
            <year>2014</year>
            <month>May</month>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>238</fpage>
            <page-range>238-46</page-range>
            <pub-id pub-id-type="pmid">24932027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sandberg</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Bridge</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.</article-title>
            <source>Cancer Genet Cytogenet</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>145</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-30</page-range>
            <pub-id pub-id-type="pmid">12885459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43056.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khuu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jaffe</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Siegal</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Examination of tumor and tumor-like conditions of bone.</article-title>
            <source>Ann Diagn Pathol</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>364</fpage>
            <page-range>364-9</page-range>
            <pub-id pub-id-type="pmid">10594288</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
